scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.99.16.2090 |
P698 | PubMed publication ID | 10217647 |
P2093 | author name string | Heusch G | |
Erbel R | |||
Haude M | |||
Ge J | |||
Liu F | |||
Baumgart D | |||
Görge G | |||
Grosse-Eggebrecht C | |||
P433 | issue | 16 | |
P304 | page(s) | 2090-2097 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries | |
P478 | volume | 99 |
Q48280776 | A case of takotsubo cardiomyopathy associated with epileptic seizure: reversible left ventricular wall motion abnormality and ST-segment elevation |
Q37692816 | Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation |
Q57303695 | An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events |
Q36360710 | Antagonism of Nav channels and α1-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine. |
Q38018510 | Calcium antagonists in myocardial ischemia/reperfusion--update 2012. |
Q26784294 | Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy |
Q33959651 | Coronary microcirculation: physiology and pharmacology |
Q37738588 | Coronary microcirculatory pathophysiology: can we afford it to remain a black box? |
Q30487553 | Coronary microvascular resistance: methods for its quantification in humans |
Q33913167 | Coronary responses to cold air inhalation following afferent and efferent blockade. |
Q33955008 | Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. |
Q99594675 | Distribution and relative expression of vasoactive receptors on arteries |
Q64090272 | Effects of Ivabradine on Residual Myocardial Ischemia after PCI Evaluated by Stress Echocardiography |
Q78818561 | Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background |
Q38113445 | Fractional flow reserve as a surrogate for inducible myocardial ischaemia |
Q38187020 | Fractional flow reserve-guided percutaneous coronary intervention: does coronary pressure never lie? |
Q36021761 | Fractional flow reserve: physiological basis, advantages and limitations, and potential gender differences |
Q34347226 | Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells |
Q37068649 | Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents |
Q61651349 | Impact of Alpha- and Beta-Adrenergic Receptor Blockers on Fractional Flow Reserve and Index of Microvascular Resistance |
Q37578269 | Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia. |
Q38986970 | Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention |
Q38797276 | Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction |
Q34531254 | MIBG imaging |
Q36054473 | Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta |
Q33843607 | Modification of high blood pressure after myocardial infarction |
Q33971159 | Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms |
Q37942363 | Peri-interventional coronary vasomotion |
Q41987648 | Protective effect of dexmedetomidine in coronary artery bypass grafting surgery |
Q50949282 | Regulation of Coronary Blood Flow. |
Q83659593 | Reprint of: the paradox of α-adrenergic coronary vasoconstriction revisited |
Q44425347 | Role of the eNOS Glu298Asp variant on the GNB3825T allele dependent determination of ??-adrenergic coronary constriction |
Q57071453 | Similarities and differences between carotid artery and coronary artery function |
Q88131546 | Similarity between carotid and coronary artery responses to sympathetic stimulation and the role of α1-receptors in humans |
Q33613176 | The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries |
Q37933582 | The coronary circulation and blood flow in left ventricular hypertrophy |
Q24802084 | The insertion/deletion variation in the alpha2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes |
Q37860513 | The paradox of α-adrenergic coronary vasoconstriction revisited |
Q34025089 | The α₁B -adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium |
Q34171574 | Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death |
Q34606668 | Vascular control in humans: focus on the coronary microcirculation |
Q41666932 | Vasodilation Responses to Non-Selective α-Adrenergic Blockage of Coronary Bypass Grafts in Diabetic and Non-Diabetic Patients: In Vitro Study. |
Q44010223 | Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy |
Q73298199 | [Anti-ischemic effect of verapamil within the scope of interventional recanalization] |
Q77892282 | [Current aspects on differentiating thoracic pain symptoms] |
Q77763038 | [Physiologic evaluation of coronary circulation. Role of invasive and non invasive techniques] |
Search more.